And what about this company they partnered with to
Post# of 36563
(Total Views: 420)
Posted On: 02/14/2022 4:14:50 PM
And what about this company they partnered with to sell the product in the VA hospitals? They stated while most are closed, some are opening up, so if they were working in the VA hospitals before, why were they not selling to these hospitals with this company or telling us they were and finally making revenue?
They received an investment, so excellagen should have been all over the map selling to open VA hospitals as well as others.
But silence……
We had previously launched Excellagen and in December of 2019 had ramped it up to over $500,000 in sales that month. Unfortunately, the Covid Pandemic hit and stopped our sales in its track as elective surgeries and new sales calls were shut down completely to the focused Sales Channel. We had signed an Agreement with AvMedical which has a national contract with the VA. This created more opportunity within the entire VA system. Excellagen is looked at as a best in class wound healing product. The FDA has authorized its use in 17 different indications, and we had already completed our tests within the VA and gained acceptance. Now, some of the major metropolitan VA centers are still closed to us, but many have reopened. We received an exclusive investment into the restart of revenues activities this week. The use of funds will be used to
They received an investment, so excellagen should have been all over the map selling to open VA hospitals as well as others.
But silence……
We had previously launched Excellagen and in December of 2019 had ramped it up to over $500,000 in sales that month. Unfortunately, the Covid Pandemic hit and stopped our sales in its track as elective surgeries and new sales calls were shut down completely to the focused Sales Channel. We had signed an Agreement with AvMedical which has a national contract with the VA. This created more opportunity within the entire VA system. Excellagen is looked at as a best in class wound healing product. The FDA has authorized its use in 17 different indications, and we had already completed our tests within the VA and gained acceptance. Now, some of the major metropolitan VA centers are still closed to us, but many have reopened. We received an exclusive investment into the restart of revenues activities this week. The use of funds will be used to
(1)
(0)